Home  About us  Contact
 

Male Breast (male + breast)

Distribution by Scientific Domains
Medical Sciences100%

Terms modified by Male Breast

  • male breast cancer
    		•
  • male breast carcinoma
    		•

    Selected Abstracts

    Ductal Carcinoma in situ (DCIS) of the Male Breast

    THE BREAST JOURNAL, Issue 3 2004
    Ali Zakhireh MD
    No abstract is available for this article. [source]

    Male Breast: Apocrine Ductal Papilloma with Psammoma Bodies

    THE BREAST JOURNAL, Issue 3 2004
    FRCP(C), FRCPath, Jasim M. Radhi MB
    No abstract is available for this article. [source]

    Management of gynaecomastia: an update

    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, Issue 7 2007
    P. Gikas
    Summary Gynaecomastia, a benign enlargement of the male breast as a result of proliferation of the glandular component, is common, being present in 30,50% of healthy men. It may be an incidental finding, an acute unilateral or bilateral tender breast enlargement or a progressive painless enlargement of the male breast. A general medical history and careful physical examination, looking for features suggestive of breast cancer, often suffice for evaluation in patients without symptoms or those with incidentally discovered breast enlargement. If the gynaecomastia is of recent onset, a more detailed evaluation, including selected laboratory tests to search for an underlying cause is necessary. Treatment depends on the cause: an offending drug may need to be withdrawn or alternatively radiation, surgery and/or medical therapy may be necessary. The use of a combination of surgical excision and liposuction through a periareolar incision represents the surgical approach of choice. [source]

    Cancer of the male breast

    INTERNATIONAL JOURNAL OF DERMATOLOGY, Issue 12 2000
    Joseph C. English III MD
    First page of article [source]

    Case of fibromatosis of male breast

    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, Issue 2007
    A Li
    SUMMARY Extra-abdominal fibromatosis of the breast is rare with the clinical and radiological features closely resembled malignant breast tumour. We describe, in a 40-year-old Chinese male patient with a palpable left breast mass, the clinical, radiological and pathological features of this benign though locally aggressive tumour. [source]

    Bilateral Orbital Metastases as the Presenting Finding in a Male Patient with Breast Cancer: A Case Report and Review of the Literature

    THE BREAST JOURNAL, Issue 3 2000
    Michael Stuntz MD
    Abstract: Breast cancer in men has traditionally been thought to be substantially different from that in women. As more becomes known about this relatively rare entity, the similarities between genders become more striking than the differences. Carcinoma of the male breast is an uncommon disease occurring in less than 1% of all breast cancers. Male breast carcinoma is staged similarly to female breast cancer using the American Joint Committee Clinical Staging System. As in women, axillary nodal status is the strongest predictor of outcome. Distant metastasis to bones, soft tissue, lungs, and liver have been widely reported in men with breast cancer. This case report provides a rather rare presentation of a man with breast carcinoma with bilateral orbital metastasis as an initial clinical presentation. [source]

    Review article Male breast cancer , an andrological disease: risk factors and diagnosis

    ANDROLOGIA, Issue 6 2004
    W. Krause
    Summary. Gynaecomastia, the enlargement of the male breast, is considered as an andrological disease. To date, a review on male breast cancer (MBC) has not been published in an andrological journal. The papers underlying this review were published from authors of different institutions: Clinical Genetics, Dermatology, Gynaecology, Internal Medicine, Oncology, Pathology, Psychiatry, Radiology and Surgery. MBC accounts for approximately 1% of breast cancer patients. A total of 182 men died of breast cancer in 1999, in Germany. In the US, 1500 new cases per year occur. MBC accounts for <5% of surgically removed breast lumps. Diseases with increased oestrogen action increase the risk of MBC. Mutations of distinct genes are estimated to account for up to roughly 10% of MBC. BRCA1 and BRCA2 gene mutations are responsible for approximately 80% of the families with hereditary breast cancer. The diagnosis of MBC is not possible without histological examination. Different diagnostic procedures such as clinical diagnosis, sonography, mammography, fine-needle biopsy and core needle facilitate the decision whether a biopsy is necessary. [source]

    In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute,

    CANCER, Issue 8 2005
    M.P.H., William F. Anderson M.D.
    Abstract BACKGROUND In situ breast carcinoma is not so well characterized for men as for women. METHODS Therefore, the authors of the current study compared male and female in situ and invasive breast carcinomas in the Surveillance, Epidemiology, and End Results (SEER) database of the National Cancer Institute to document these patterns. RESULTS In situ breast carcinomas composed 9.4% of all male (n = 280 of 2984) and 11.9% of all female breast carcinomas (n = 53,928 of 454,405) during the years 1973,2001. In situ rates rose 123% for men and 555% for women over this time period; whereas distant disease rates fell for both genders. Median ages at diagnosis were 62 years for in situ and 68 years for invasive breast carcinoma among men, compared with 58 years for in situ and 62 years for invasive breast carcinoma among women. Papillary in situ and invasive architectural types were more common among men than women. In contrast, lobular tumors were more common among women than men. Breast cancer-specific survival was similar among men and women, whereas overall survival was worse for men than women. CONCLUSION In situ male breast carcinoma is a rare disease, occurring at older ages and with different architectural types than its more common female counterpart. Gender-specific histopathologic differences probably reflect anatomic differences among the normal female and vestigial male breast. Rising in situ male breast carcinoma incidence rates over the past three decades suggest earlier detection over time, irrespective of mammography, because men do not participate in routine screening mammography. Worse overall survival for men than women possibly results from age-dependent comorbid illnesses. Cancer 2005. Published 2005 American Cancer Society. [source]